S2P intramembrane protease RseP degrades small membrane proteins and suppresses the cytotoxicity of intrinsic toxin HokB
mBio · 2023
DOI: 10.1128/mbio.01086-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Tatsuhiko Yokoyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Life and Medical Sciences, Kyoto University, Sakyo-ku , Kyoto, Japan. Hauptthemen laut MEDLINE: Escherichia coli Proteins, Escherichia coli, Membrane Proteins, Bacterial Toxins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Platform Project for Supporting in Drug Discovery and Life Science Research form the Japan Agency for Medical Research and Development, Cooperative Research Program (Joint Usage/Research Centerprogram) of the Institute for Frontier Life and Medical Sciences Kyoto University.
Abstract (Originalsprache)
The site2 - protease (S2P) family of intramembrane proteases (IMPs) is conserved in all kingdoms of life and cleaves transmembrane proteins within the membrane to regulate and maintain various cellular activities. RseP, an Escherichia coli S2P peptidase, is involved in the regulation of gene expression through the regulated cleavage of the two target membrane proteins (RseA and FecR) and in membrane quality control through the proteolytic elimination of remnant signal peptides. RseP is expected to have additional substrates and to be involved in other cellular processes. Recent studies have shown that cells express small membrane proteins (SMPs; single-spanning membrane proteins of approximately 50–100 amino acid residues) with crucial cellular functions. However, little is known about their metabolism, which affects their functions. This study investigated the possible RseP-catalyzed cleavage of E. coli SMPs based on the apparent similarity of the sizes and structures of SMPs to those of remnant signal peptides. We screened SMPs cleaved by RseP in vivo and in vitro and identified 14 SMPs, including HokB, an endogenous toxin that induces persister formation, as potential substrates. We demonstrated that RseP suppresses the cytotoxicity and biological functions of HokB. The identification of several SMPs as novel potential substrates of RseP provides a clue to a comprehensive understanding of the cellular roles of RseP and other S2P peptidases and highlights a novel aspect of the regulation of SMPs. IMPORTANCE Membrane proteins play an important role in cell activity and survival. Thus, understanding their dynamics, including proteolytic degradation, is crucial. E. coli RseP, an S2P family intramembrane protease, cleaves membrane proteins to regulate gene expression in response to environmental changes and to maintain membrane quality. To identify novel substrates of RseP, we screened small membrane proteins (SMPs), a group of proteins that have recently been shown to have diverse cellular functions, and identified 14 potential substrates. We also showed that RseP suppresses the cytotoxicity of the intrinsic toxin, HokB, an SMP that has been reported to induce persister cell formation, by degrading it. These findings provide new insights into the cellular roles of S2P peptidases and the functional regulation of SMPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Life and Medical Sciences, Kyoto University, Sakyo-ku , Kyoto, Japan.
- Graduate School of Medical Life Science, Yokohama City University, Tsurumi-ku , Yokohama, Japan.
ORCID-Profile: Tatsuhiko Yokoyama, Terukazu Nogi, Yohei Hizukuri, Yoshinori Akiyama
Förderung
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Platform Project for Supporting in Drug Discovery and Life Science Research form the Japan Agency for Medical Research and Development
- Cooperative Research Program (Joint Usage/Research Centerprogram) of the Institute for Frontier Life and Medical Sciences Kyoto University
- Institute for Frontier Life and Medical Sciences, Kyoto University for INFRONT Office of Director's Research Grant Program (2020)
- Institute for Fermentation, Osaka (IFO)
Zitieren
APA
Yokoyama, T., Yamagata, Y., Honna, S., Mizuno, S., Katagiri, S., Oi, R., Nogi, T., Hizukuri, Y., & Akiyama, Y. (2023). S2P intramembrane protease RseP degrades small membrane proteins and suppresses the cytotoxicity of intrinsic toxin HokB. mBio. https://doi.org/10.1128/mbio.01086-23
Vancouver
Yokoyama T, Yamagata Y, Honna S, Mizuno S, Katagiri S, Oi R, et al. S2P intramembrane protease RseP degrades small membrane proteins and suppresses the cytotoxicity of intrinsic toxin HokB. mBio. 2023. doi:10.1128/mbio.01086-23
BibTeX
@article{Yokoyama2023,
author = {Yokoyama, Tatsuhiko and Yamagata, Yutaro and Honna, Saisei and Mizuno, Shinya and Katagiri, Shizuka and Oi, Rika and Nogi, Terukazu and Hizukuri, Yohei and Akiyama, Yoshinori},
title = {S2P intramembrane protease RseP degrades small membrane proteins and suppresses the cytotoxicity of intrinsic toxin HokB},
journal = {mBio},
year = {2023},
doi = {10.1128/mbio.01086-23}
}
EUVIMED